Brief: Omega Therapeutics Reports Fourth Quarter And Full Year 2022 Financial Results And Provides Corporate Update
01/03/2023 15:08
Omega Therapeutics Inc OMGA.O :
* OMEGA THERAPEUTICS REPORTS FOURTH QUARTER AND FULL YEAR
2022
FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE
* OMEGA THERAPEUTICS INC - QTRLY NET LOSS PER COMMON STOCK
ATTRIBUTABLE TO COMMON STOCKHOLDERS, BASIC AND DILUTED $0.64
Source text for Eikon: ID:nGNX9THdnh
Further company coverage: OMGA.O
Recent news on Omega Liquidating
See all newsBrief: Omega Therapeutics Files For Chapter 11 Bankruptcy In U.S. - Court Filing
Brief: Omega Therapeutics Announces Entry Into New Financing Facilities To Fund Sale Process And Wind Down Of Any Remaining Co Assets
Brief: Omega Therapeutics Receives Notice Of Default Under The Loan And Security Agreement Between Company And Banc Of California
U.S. RESEARCH ROUNDUP- Applied Materials, Disney, Walmart
Brief: Flagship Pioneering Announces Appointment Of Junaid Bajwa As Senior Partner, Head Of United Kingdom, And Science Partner For Pioneering Intelligence